Suppr超能文献

子宫内膜异位症患者全身和子宫内免疫群体的改变。

Alteration of systemic and uterine endometrial immune populations in patients with endometriosis.

机构信息

Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, IL, USA.

Department of Obstetrics & Gynecology, Southern Illinois University School of Medicine, Springfield, IL, USA.

出版信息

Am J Reprod Immunol. 2021 Mar;85(3):e13362. doi: 10.1111/aji.13362. Epub 2020 Oct 29.

Abstract

PROBLEM

Endometriosis is defined as growth of endometrial tissue in ectopic locations; it is associated with infertility and chronic pain and affects ~12% of reproductive-aged women. Although inflammation is known to play a key role in endometriosis, knowledge related to immune phenotypes associated with this disease is lacking. This study aimed to characterize immune profiles in patients with endometriosis, to assess inflammatory mediators, to and determine if surgical and/or hormonal therapies restore immune homeostasis.

METHODS OF STUDY

Samples from nine controls and 20 histologically confirmed endometriosis patients were collected upon surgery and ~1-3 weeks post-surgical intervention. Subjects were either not utilizing hormonal suppression or were currently on monophasic hormonal therapy. Tolerant regulatory T cells (Tregs = natural [nTregs] +inducible [iTregs]) and inflammatory T helper 17 (Th17) cells were identified in peripheral blood via flow cytometry and within the eutopic/ectopic endometrial tissues via immunohistochemistry and real-time-qPCR. Cytokines were assessed via 10-plex-ELISA.

RESULTS

Patients with endometriosis not utilizing hormonal therapy exhibited lower iTregs (tolerant), greater Th17 (inflammatory), and a reduction in Treg/Th17 ratio (P < .05), indicative of systemic inflammation. Treg and Th17 localizations were enhanced within the ectopic endometrial implant, which promotes lesion development. Hormonal therapy decreased systemic and local inflammation (eutopic/ectopic endometrium) via decreased iTregs and Th17 cells in patients with endometriosis (P < .05). Thus, imbalance within immune populations correlated with increased inflammation in patients with endometriosis, which was mitigated by hormonal therapy.

CONCLUSIONS

Patients with endometriosis exhibited systemic and localized inflammation within ectopic and endometrial tissues. Hormonal therapy dampened inflammation caused by disease.

摘要

问题

子宫内膜异位症被定义为子宫内膜组织在异位部位的生长;它与不孕和慢性疼痛有关,影响约 12%的育龄妇女。虽然已知炎症在子宫内膜异位症中起关键作用,但与这种疾病相关的免疫表型的知识却缺乏。本研究旨在描述子宫内膜异位症患者的免疫特征,评估炎症介质,并确定手术和/或激素治疗是否能恢复免疫平衡。

研究方法

在手术时以及手术干预后约 1-3 周,从 9 名对照者和 20 名经组织学证实的子宫内膜异位症患者中采集样本。这些患者要么没有使用激素抑制,要么正在接受单相激素治疗。通过流式细胞术在外周血中鉴定出耐受调节性 T 细胞(Tregs=天然 [nTregs]+诱导性 [iTregs])和炎症性辅助性 T 细胞 17(Th17)细胞,通过免疫组织化学和实时 qPCR 在子宫内/异位子宫内膜组织中鉴定出这些细胞。通过 10 重酶联免疫吸附试验评估细胞因子。

结果

未使用激素治疗的子宫内膜异位症患者表现出较低的 iTregs(耐受)、更高的 Th17(炎症)和 Treg/Th17 比例降低(P<0.05),表明存在全身炎症。Treg 和 Th17 的定位在异位子宫内膜植入物中增强,促进了病变的发展。在子宫内膜异位症患者中,激素治疗通过降低 iTregs 和 Th17 细胞,减少了全身和局部炎症(子宫内膜/异位子宫内膜)(P<0.05)。因此,免疫人群的失衡与子宫内膜异位症患者的炎症增加相关,而激素治疗减轻了这种炎症。

结论

子宫内膜异位症患者在异位和子宫内膜组织中表现出全身和局部炎症。激素治疗减轻了疾病引起的炎症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验